Did you know that 40% of medical device submissions are delayed due to inadequate clinical evaluations? In the highly competitive medical device market, mastering clinical evaluations is not just a regulatory hurdle but a strategic imperative. Effective clinical evaluations can accelerate market entry, enhance brand reputation, and ensure sustained competitive superiority. This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements. Through real-world case studies and actionable insights, discover how to achieve excellence and maintain a competitive edge in the medical device market.
Why rigorous clinical evaluations matter: strategies to boost safety and compliance
This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements
You may also like
Trending Articles
You may also like
Drug Delivery
EpilepsyGTx selects ClearPoint Neuro technology for Phase I/IIa epilepsy gene therapy trial
The partnership will support MRI-guided delivery of investigational gene therapy EPY201 in first-in-human trials targeting focal refractory epilepsy, where precision administration is "key to efficacy and safety"
Digital
Camgenium launches pre-certified Foundation Platform for connected medical device development
The infrastructure combines IEC 62304-compliant firmware, ISO 27001 cloud hosting and automated regulatory reporting, letting OEM teams focus engineering effort on clinical differentiation rather than compliance build-out
Manufacturing
IMA MED-TECH launches ASSEMBLA modular assembly platform for medical devices across full lifecycle
The engineer-to-order system scales from 20 to 500+ parts per minute on a single extendable frame, supporting injectables, inhalers, diagnostics and wearables from clinical trials through high-volume industrial production